| Originele taal-2 | English |
|---|---|
| Pagina's (van-tot) | 1104-1108 |
| Aantal pagina's | 9 |
| Tijdschrift | Journal of the American Academy of Dermatology |
| Volume | 87 |
| Nummer van het tijdschrift | 5 |
| DOI's | |
| Status | Published - nov.-2022 |
Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis : Interim results from the PEDISTAD Real-World Registry. / Paller, Amy S.; Guttman-Yassky, Emma; Schuttelaar, Marie L.A. et al.
In: Journal of the American Academy of Dermatology, Vol. 87, Nr. 5, 11.2022, blz. 1104-1108.Onderzoeksoutput › Academic › peer review
TY - JOUR
T1 - Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis
T2 - Interim results from the PEDISTAD Real-World Registry
AU - Paller, Amy S.
AU - Guttman-Yassky, Emma
AU - Schuttelaar, Marie L.A.
AU - Irvine, Alan D.
AU - Baselga, Eulalia
AU - Kataoka, Yoko
AU - Antila, Martti
AU - de Bruin-Weller, Marjolein S.
AU - Marcoux, Danielle
AU - Abramova, Alvina
AU - Rizova, Elena
AU - Liu, Chunyuan
AU - Zhang, Annie
N1 - Funding Information: Funding sources: This research was sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.Medical writing and editorial assistance were provided by Yunyu Huang, PhD, of Excerpta Medica, funded by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. Funding Information: Dr Paller has been an investigator for AbbVie, AnaptysBio, BMS, Eli Lilly, Galderma, Incyte, LEO Pharma, Janssen, Novartis, Regeneron Pharmaceuticals, Inc, Sanofi; and a consultant for AbbVie, Abeona, Almirall, Asana Biosciences, Boehringer Ingelheim, BridgeBio Pharma, Dermavant, Dermira, Eli Lilly, Exicure, Forte, Galderma, Incyte, InMed Pharmaceuticals, Janssen, LEO Pharma, Lifemax, Novartis, Pfizer, Rapt Therapeutics, Regeneron, Sanofi Genzyme, Sol Gel, UCB. Dr Guttman-Yassky has been investigator for AbbVie, BMS, Eli Lilly, Galderma, Glenmark, GlaxoSmithKline, LEO Pharma, Pfizer, Regeneron Pharmaceuticals, Inc, Sanofi; a consultant for AbbVie, Anacor, Asana Biosciences, Daiichi Sankyo, DBV, Dermira, Eli Lilly, Galderma, Glenmark, GlaxoSmithKline, Kiniksa Pharmaceuticals, Kyowa, LEO Pharma, Menlo Therapeutics, Novartis, Pfizer, Realm, Regeneron Pharmaceuticals, Inc, Sanofi; received research grants from AbbVie, BMS, Dermira, Galderma, Innovaderm, Janssen, LEO Pharma, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc, Sanofi. Dr Schuttelaar has been an advisory board member for Eli Lilly, LEO Pharma, Pfizer, Sanofi Genzyme; an investigator for AbbVie, Novartis, Regeneron Pharmaceuticals, Inc, Sanofi Genzyme; a consultant for Regeneron Pharmaceuticals, Inc; and has received research grants from Novartis, Sanofi Genzyme. Dr Irvine has received honoraria for consultancy from AbbVie, Arena Pharmaceuticals, BenevolentAI, Chugai, Dermavant, Eli Lilly, Genentech, LEO Pharma, Menlo Therapeutics, Novartis, Pfizer, Regeneron, Sanofi, UCB. Dr Baselga has been an investigator for AbbVie, Boehringer Ingelheim, Dermira, Eli Lilly, LEO Pharma, Pfizer, Novartis; and a consultant for Almirall, Galderma, Novartis, Pfizer, Pierre-Fabre, Regeneron Pharmaceuticals, Inc, Sanofi Genzyme. Dr Kataoka has received honoraria for lectures and research grants from Sanofi; and research grants from AbbVie, Eli Lilly, LEO Pharma, Maruho, Pfizer, Otsuka. Dr Antila has participated in clinical studies funded by AbbVie, AstraZeneca, EMS, Eurofarma, GlaxoSmithKline, Humanigen, Janssen, Novartis, Sanofi Genzyme; and participated in conferences and consultancy activities for Aché, AstraZeneca, Chiesi, Eurofarma, IPI ASAC Brasil, Sanofi. Dr de Bruin-Weller has been a consultant, advisory board member, and/or speaker for AbbVie, Almirall, Eli Lilly, Galderma, Janssen, LEO Pharma, Pfizer, Regeneron Pharmaceuticals, Inc, Sanofi Genzyme, UCB. Dr Marcoux has been investigator for AbbVie, Amgen, Eli Lilly, Janssen, LEO Pharma, Novartis, Pfizer; a consultant for AbbVie, Amgen, BMS, Eli Lilly, Janssen, LEO Pharma, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc, Sanofi Genzyme, UCB; and a speaker for AbbVie, Amgen, BMS, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc, Sanofi Genzyme. Dr Abramova was an employee of Regeneron Pharmaceuticals, Inc when the study was conducted and may hold stock and/or stock options in the company. Dr Rizova was an employee of Sanofi Genzyme when the study was conducted and may hold stock and/or stock options in the company. Mr Liu is an employee of Tigermed-BDM Inc. and is working as a consultant with Sanofi. Dr Zhang is an employee of Sanofi Genzyme and may hold stock and/or stock options in the company. Funding Information: Funding sources: This research was sponsored by Sanofi and Regeneron Pharmaceuticals, Inc .
PY - 2022/11
Y1 - 2022/11
U2 - 10.1016/j.jaad.2022.01.018
DO - 10.1016/j.jaad.2022.01.018
M3 - Letter
C2 - 35081419
AN - SCOPUS:85130371095
VL - 87
SP - 1104
EP - 1108
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
SN - 0190-9622
IS - 5
ER -